JBM (Healthcare) Limited to Be Spun Off from Jacobson Pharma Corporation Limited
HONG KONG, Jan 25, 2021 - (ACN Newswire) - JBM (Healthcare) Limited ("JBM Healthcare" or "Company" and, together with its subsidiaries, the "Group"), a Hong Kong-based company that markets and distributes branded healthcare products with product footprint across Greater China, Southeast Asia and certain other countries, today announced details of the proposed listing of its shares on the Main Board of The Stock Exchange of Hong Kong Limited ("SEHK"). Mr. Patrick Wong, Chief Executive Officer and Executive Director of JBM Healthcare (left) and Dr. Chu Ka Wing, President of the Proprietary Chinese Medicine Business and Executive Director of JBM Healthcare (right)Highlights- The fourth largest brand operator that carries both over-the-counter ("OTC") proprietary medicines and OTC proprietary Chinese medicines in Hong Kong in 2019 by revenue - As a subsidiary of Jacobson Pharma Corporation Limited ("Jacobson Pharma"; Stock Code: 2633), JBM Healthcare is a unique field player with drug expertise and a heritage that continues to foster a corporate culture of prioritizing product efficacy and quality- Notable and growing brand portfolio along with a proven brand management capability. As ...
